Join BJS Academy
BJS Academy>Randomized clinical ...>Neoadjuvant chemorad...
Normal View Dyslexic View

Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial

19 July 2023
Randomized clinical trials Colorectal
Gerard J-P, Barbet N, Schiappa R, Magne N, Martel I, Mineur L et al, on behalf of the ICONE group.

Lancet Gastrohepatol 2023; 8: 356-367.

This study explored whether a radiotherapy booster was beneficial in 148 patients with a complete response to neoadjuvant chemoradiotherapy. Three-year preservation of the rectum was more likely after contact brachytherapy (81 per cent) versus 59 per cent for booster external beam radiotherapy, P=0.0026. The effect was greatest for tumours <3cm in diameter.

Comment: Management of rectal tumours with the aim to avoid ablative surgery is evolving.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct103
Randomized clinical trials
Randomized clinical trials
Colorectal
Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial
Gerard J-P, Barbet N, Schiappa R, Magne N, Martel I, Mineur L et al, on behalf of the ICONE group.
19072023
Lancet Gastrohepatol 2023; 8: 356-367.
This study explored whether a radiotherapy booster was beneficial in 148 patients with a complete response to neoadjuvant chemoradiotherapy. Three-year preservation of the rectum was more likely after contact brachytherapy (81 per cent) versus 59 per cent for booster external beam radiotherapy, P=0.0026. The effect was greatest for tumours <3cm in diameter.
Comment: Management of rectal tumours with the aim to avoid ablative surgery is evolving.
Published on: 19 July 2023
Article ID: rct103

Related articles

Morbidity after mechanical bowel preparation and oral antibiotics prior to rectal resection. The MOBILE2 randomized clinical trial.

Koskenvuo L, Lunkka P, Varpe P, Hyoty M, Satokari R, Haapamaki C et al.

25 September 2024

Pyridostigmine to reduce the duration of postoperative Ileus after colorectal surgery (PyRICo-RCT): randomized clinical trial.

Traeger L, Bedrikovetski S, Fitzsimmons T, Nguyen T-M, Moore JW, Lewis M et al.

7 August 2024

Sacral neuromodulation versus conservative treatment for refractory idiopathic slow-transit constipation. The randomized clinical No.2-Trial.

Heemskerk SC, Dirksen CD, van Kuijk SMJ, Benninga MA, Baeten C, Masclee AAM et al.

30 August 2024
Home
  • Normal view
  • Dyslexic view
Info
Copied!